Clinical trial Recruiting at 1 site Observational Ages Any age to 18

Investigating COVID-19 in hospitalized children in Norway

Official title: COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology

Run by University Hospital, Akershus · NCT04335773 · Data updated 2026-11-12

This study looks at how COVID-19 affects children in hospitals in Norway to see what makes some kids sicker than others and to understand the long-term effects of the virus.

More COVID-19 trials

Quick facts

Study typeObservational
AgesAny age to 18 Years
SexAll
Enrollment350 (estimated)
SponsorUniversity Hospital, Akershus
Academic / other
Locations1 site (Lørenskog)
StatusRecruiting
StartedApril 3, 2020
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedFebruary 16, 2022
Trial IDNCT04335773 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 0-18 years who are hospitalized with suspected COVID-19.

Probably not a fit

Patients over the age of 18 or those without suspected COVID-19 will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective cohort study examines COVID-19 infection among children in Norway, focusing on three main areas: epidemiological risk factors, the natural history of the disease including immunological responses, and long-term effects such as post-infectious fatigue. Children aged 0-18 years admitted to hospitals with suspected COVID-19 will be followed for six months, with those confirmed to have the virus serving as cases and those without as controls. The study aims to identify risk factors for severe outcomes, understand the immune response to the infection, and assess the prevalence of long-lasting complications.

Why it matters

Potential benefit: If successful, this study could enhance understanding of COVID-19 in children, leading to improved treatment and prevention strategies.

How similar studies have gone: Other studies have explored COVID-19 in pediatric populations, but this specific approach focusing on risk factors and long-term outcomes is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Suspected covid-19 infection and age 0-18 years

Exclusion Criteria:

Age \>18 years

Where it's running

  • Akershus universistetssykehus
    Lørenskog, Norway
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.